Target Name: POMC
NCBI ID: G5443
Review Report on POMC Target / Biomarker Content of Review Report on POMC Target / Biomarker
POMC
Other Name(s): Lipotropin beta (HUMAN) | alpha-melanocyte-stimulating hormone | Melanotropin beta | adrenocorticotropin | COLI_HUMAN | N-terminal peptide of proopiomelanocortin | Melanocyte-stimulating hormone beta | N-POMC (HUMAN) | Gamma-MSH | Beta-MSH / Beta-Endorphin_(HUMAN) | proACTH_(HUMAN) | proACTH | alpha-Melanocyte-stimulating hormone | orticotropin-lipotropin | Adrenocorticotropin | alpha-MSH | Melanotropin gamma | Melanotropin alpha | melanotropin beta | met-enkephalin | Beta-endorphin | beta-LPH | beta-MSH | ACTH | OTTHUMP00000200965 | Pro-ACTH-endorphin | Corticotropin-lipotropin | proopiomelanocortin preproprotein | melanotropin alpha | Melanocyte-stimulating hormone alpha | Proopiomelanocortin, transcript variant 2 | POC | Met-enkephalin | beta-endorphin | Adrenocorticotropic hormone | CLIP | OTTHUMP00000200966 | Lipotropin gamma | Lipotropin beta | OBAIRH | N-POC_(HUMAN) | pro-ACTH-endorphin | MSH | beta-LPH_(HUMAN) | Alpha-melanocyte-stimulating hormone | Beta-MSH | Beta-MSH / Beta-Endorphin fusion protein | Corticotropin-like intermediary peptide | beta-melanocyte-stimulating hormone | OTTHUMP00000200964 | opiomelanocortin prepropeptide | NPP | adrenocorticotropic hormone | N-POMC_(HUMAN) | LPH | Proopiomelanocortin, transcript variant 4 | POMC variant 1 | proopiomelanocortin | Proopiomelanocortin | corticotropin-like intermediary peptide | N-terminal fragment of pro-opiomelancortin | POMC variant 4 | Proopiomelanocortin preproprotein | Proopiomelanocortin, transcript variant 1 | lipotropin beta | corticotropin-lipotropin | POMC variant 3 | Beta-melanocyte-stimulating hormone | OTTHUMP00000119991 | Corticotropin | gamma-MSH | N-POMC | Gamma-LPH | melanotropin gamma | POMC variant 2 | Pro-opiomelanocortin | lipotropin gamma | orticotropin-like intermediary peptide | proAdrenocorticotropic hormone | Beta-LPH | Potential peptide | Proopiomelanocortin, transcript variant 3 | Alpha-MSH | gamma-LPH

POMC: A Drug Target / Disease Biomarker

POMC (Porcine Somatotropin-like) is a protein produced by the pituitary gland that is responsible for regulating various bodily functions. It is one of the most well-known proteins produced by the pituitary gland, and its levels are highly variable throughout the day. POMC has been identified as a potential drug target and has been shown to play a role in a variety of physiological processes in both humans and pigs.

POMC is a member of the Somatotropin family, which includes a number of other proteins that are involved in the regulation of growth and development. These proteins, known as growth hormone (GH), somatotropin (ST), and its precursor, growth hormone receptor (GHR), are all produced by the pituitary gland and play important roles in the development and maintenance of tissues and organs in the body.

POMC is produced by the pituitary gland in response to the presence of growth hormone (GH), which is released by the anterior lobe of the pituitary gland in response to the levels of prolactin (PRL) in the blood. POMC is a 26-kDa protein that is highly variable in its length and composition. It consists of a pre-伪 chain (120 amino acids), a 伪 chain (54 amino acids), and a post-伪 chain (96 amino acids). The pre-伪 chain and 伪 chain are involved in the formation of the mature protein, while the post-伪 chain is responsible for the functions that POMC is involved in.

POMC plays a number of important roles in the body. It is involved in the regulation of growth and development, as well as the maintenance of normal thyroid function. It is also involved in the regulation of sexual function and has been shown to play a role in the development and maintenance of reproductive tissues in both humans and pigs.

In addition to its role in the regulation of growth and development, POMC is also a potential drug target. Its high expression in the brain and its involvement in a variety of physiological processes make it an attractive target for the development of new treatments for a variety of neurological and endocrine disorders.

POMC has also been shown to play a role in the regulation of metabolism and energy homeostasis. It is involved in the regulation of glucose and lipid metabolism, as well as the production of energy in the form of muscle contraction.

In conclusion, POMC is a protein produced by the pituitary gland that is involved in a variety of physiological processes in both humans and pigs. Its high expression in the brain and its potential as a drug target make it an attractive target for the development of new treatments for a variety of neurological and endocrine disorders. Further research is needed to fully understand the role of POMC in the regulation of growth and development, as well as its potential as a drug target.

Protein Name: Proopiomelanocortin

Functions: Stimulates the adrenal glands to release cortisol

The "POMC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about POMC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

POMGNT1 | POMGNT2 | POMK | POMP | POMT1 | POMT2 | POMZP3 | PON1 | PON2 | PON3 | POP1 | POP4 | POP5 | POP7 | POPDC2 | POPDC3 | POR | PORCN | POSTN | POT1 | POT1-AS1 | Potassium Channels | POTEA | POTEB | POTEB2 | POTEB3 | POTEC | POTED | POTEE | POTEF | POTEG | POTEH | POTEI | POTEJ | POTEKP | POTEM | POU-Domain transcription factors | POU1F1 | POU2AF1 | POU2AF2 | POU2AF3 | POU2F1 | POU2F2 | POU2F3 | POU3F1 | POU3F2 | POU3F3 | POU3F4 | POU4F1 | POU4F2 | POU4F3 | POU5F1 | POU5F1B | POU5F1P3 | POU5F1P4 | POU5F1P5 | POU5F2 | POU6F1 | POU6F2 | PP12613 | PP2D1 | PP7080 | PPA1 | PPA2 | PPAN | PPAN-P2RY11 | PPARA | PPARD | PPARG | PPARGC1A | PPARGC1B | PPAT | PPATP1 | PPBP | PPBPP2 | PPCDC | PPCS | PPDPF | PPDPFL | PPEF1 | PPEF2 | PPFIA1 | PPFIA2 | PPFIA3 | PPFIA4 | PPFIBP1 | PPFIBP2 | PPHLN1 | PPIA | PPIAL4A | PPIAL4D | PPIAL4E | PPIAL4F | PPIAL4G | PPIAL4H | PPIAP19 | PPIAP21 | PPIAP22 | PPIAP29 | PPIAP30